Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma

Authors

Beth L. Nordstrom, Evidera
Melissa Hamilton, Bristol Myers Squibb
Jenna M. Collins, Evidera
Dennis Earle, Bristol Myers Squibb
Ying Zhang, Bristol Myers Squibb
Shivani Srivastava, Bristol Myers Squibb
Leonel Hernandez-Aya, Washington University School of Medicine in St. Louis

Journal

Future Oncology

Publication Date

2022

Volume

18

Issue

11

First Page

1343

Last Page

1355

Document Type

Open Access Publication

DOI

10.2217/fon-2021-0340

Rights and Permissions

Nordstrom, B. L., Hamilton, M., Collins, J. M., Earle, D., Zhang, Y., Srivastava, S., & Hernandez-Aya, L. (2022). Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma. Future oncology (London, England), 18(11), 1343–1355. doi.org/10.2217/fon-2021-0340. This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. For full bibliographic citation, please refer to the version available at www.futuremedicine.com.

Recommended Citation

Nordstrom, Beth L.; Hamilton, Melissa; Collins, Jenna M.; Earle, Dennis; Zhang, Ying; Srivastava, Shivani; and Hernandez-Aya, Leonel, "Treatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma." Future Oncology. 18, 11. 1343 - 1355. (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11698